SLP
Undervalued by 76.4% based on the discounted cash flow analysis.
Market cap | $348.52 Million |
---|---|
Enterprise Value | $343.05 Million |
Dividend Yield | $0.06 (0.346220427005193%) |
Earnings per Share | $0.5 |
Beta | 0.97 |
Outstanding Shares | 20,097,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 48.26 |
---|---|
PEG | -203.59 |
Price to Sales | 5.71 |
Price to Book Ratio | 1.9 |
Enterprise Value to Revenue | 4.36 |
Enterprise Value to EBIT | 29.78 |
Enterprise Value to Net Income | 47 |
Total Debt to Enterprise | 0.02 |
Debt to Equity | 0.03 |
No data
No data
Simulations Plus, Inc., is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. With its subsidiaries, Cognigen, DILIsym Services, and...